NVOS Novo Integrated Sciences
- 0.5852
- +0.0240+4.28%
- 0.5955
- +0.0103+1.76%
Novo Integrated Sciences News
Novo Integrated Sciences Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Revenue.
Novo Integrated Sciences Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Revenue.
Novo Integrated Sciences Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results.
Novo Integrated Sciences Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results.
Novo Integrated Sciences Q2 EPS $(0.16) Up From $(0.59) YoY, Sales $3.17M Up From $2.56M YoY
Novo Integrated Sciences (NASDAQ:NVOS) reported quarterly losses of $(0.16) per share. This is a 72.88 percent increase over losses of $(0.59) per share from the same period last year. The company re
Novo Integrated Sciences 2Q Loss/Shr 16c >NVOS
Novo Integrated Sciences 2Q Loss/Shr 16c >NVOS
Novo Integrated Sciences: Continue to Work With Certain Prospective Fincl Partners to Close Previously Announced Non-Traditional Financing Opportunities >NVOS
Novo Integrated Sciences: Continue to Work With Certain Prospective Fincl Partners to Close Previously Announced Non-Traditional Financing Opportunities >NVOS
Earnings Flash (NVOS) NOVO INTEGRATED SCIENCES Reports Q2 Revenue $3.2M
04:30 PM EDT, 04/15/2024 (MT Newswires) -- Earnings Flash (NVOS) NOVO INTEGRATED SCIENCES Reports Q2 Revenue $3.2M
Press Release: Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results BELLEVUE, Wash.--(BUSINESS WIRE)--April 15, 2024-- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "
Novo Integrated Sciences Secures Convertible Note Financing
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
Both the Mast Hill $3,500,000 Note and the FirstFire $277,777 Note were Paid in Full with Cash Proceeds from the Streeterville Note Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ:RLYB) rose sharply in today's pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individ
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLongeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. The market value of their outstanding shares is at $9.6 million. PetVivo Hldgs (NASDAQ:PETV)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) stock rose 85.5% to $4.86 during Thursday's pre-market session. The market value of their outstanding shares is at $800.0 million. Candel Therapeutics (NASDAQ
Novo Integrated Sciences Advances With Strategic Financial Moves
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: Purchase and Sale Agreement – Ophir Collection: As previously
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement With Futura Surgicare Pvt Ltd.
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International, LLC ("CCI"), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement
Novo Integrated Sciences Secures Nasdaq Compliance Waiver
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
The Waiver Exempts any determination of non-compliance associated to Nasdaq's Minimum Bid Price Requirement Rule Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today the Company has
Novo Integrated Sciences:Robert Oliva Appointed as President, Succeeds Christopher David, Who Remains Oper Chief and a Member of Bd of Directors >NVOS
Novo Integrated Sciences:Robert Oliva Appointed as President, Succeeds Christopher David, Who Remains Oper Chief and a Member of Bd of Directors >NVOS
Novo Integrated Sciences Appoints New President
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today Mr. Robert Oliva has been appointed as the Company's new President. Mr. Oliva succeeds Mr. Christopher David, who remains as the
Analysis
Price Target
No Data
